H3 Biomedicine Bristol-Myers Squibb, H3 Biomedicine Form Cancer Immunotherapy Alliance H3, a subsidiary of Japanese drugmaker Eisai, is developing personalized cancer treatments targeting genomic alterations, including aberrant RNA splicing. Foundation Medicine, H3 Biomedicine Partner to ID Cancer Drug Targets The partnership marries Foundation's genomic knowledgebase with H3's drug discovery engine and computational biology platform. BGI, H3 Biomedicine Strike Sequencing Data Publishing Pact NEW YORK (GenomeWeb News) – BGI and H3 Biomedicine today announced they will sequence and publish data from next-generation sequencing-based research on pre-clinical cancer models. H3 Biomedicine's CEO Says Bioinformatics Plays 'Big Role' in Oncology Drug Discovery Efforts Premium This article has been updated to clarify the tools being co-developed by H3 Biomedicine and Sage Bionetworks H3 Biomedicine, Sage Partner on Genomic Profiling Software NEW YORK (GenomeWeb News) – Cancer biotherapeutics developer H3 Biomedicine said today that it will partner with Sage Bionetworks to develop new software aimed at supporting its efforts to predict human responses to certain drugs. Oct 4, 2012 Horizon Discovery, H3 Bio Launch Screening Program for Oncology Targets Apr 30, 2012 Horizon, H3 Biomedicine Partner on Cancer Drug Targets Feb 17, 2012 H3 Biomedicine Inks Three-Year Arrangement with Compendia Premium Dec 2, 2011 In Brief This Week: Helicos BioSciences; Roche; Inform Genomics; H3 Biomedicine; Metabolon Feb 2, 2011 Eisai Invests in Development of Personalized Cancer Rx via Stake in Biotech Startup Premium Jan 28, 2011 Eisai Creates US Subsidiary H3 Biomedicine with up to $200M Breaking News SomaLogic Inks Partnership for Testing in UAE, Firm's Q2 Revenues Down 29 Percent Phenotype Ties to Rare Variants Systematically Unearthed in UK Biobank Exomes Ginkgo Bioworks, XpresCheck Receive $16M CDC Contract for SARS-CoV-2 Surveillance in US Airports Personalis, BC Cancer Partner on Study of ctDNA MRD Tests for Colorectal, Pancreatic Cancers Verogen, Gene by Gene Strike Forensic Genetics Alliance The Scan Lung Cancer Response to Checkpoint Inhibitors Reflected in Circulating Tumor DNA In non-small cell lung cancer patients, researchers find in JCO Precision Oncology that survival benefits after immune checkpoint blockade coincide with a dip in ctDNA levels. Study Reviews Family, Provider Responses to Rapid Whole-Genome Sequencing Follow-up Investigators identified in the European Journal of Human Genetics variable follow-up practices after rapid whole-genome sequencing. BMI-Related Variants Show Age-Related Stability in UK Biobank Participants Researchers followed body mass index variant stability with genomic structural equation modeling and genome-wide association studies of 40- to 72-year olds in PLOS Genetics. Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.